REXPLUS
Live / Registered — Registered (as of 19 Nov 2024)
What this means for you
Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Nov 2030: the §71 affidavit of use).
Record
- Serial number
- 79392289
- Registration number
- 7567806
- Mark type
- Word mark
- Filed
- 31 Jan 2024
- Published for opposition
- 03 Sept 2024
- Registered
- 19 Nov 2024
- Next maintenance filing
- §71 affidavit of use, due by 19 Nov 2030 (grace period to 19 May 2031)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases and disorders
Owner
Prosecution history
- 12 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 27 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 19 Dec 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 19 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTICE OF PUBLICATION
- 01 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jul 2024 — ASSIGNED TO EXAMINER
- 09 Apr 2024 — APPLICATION FILING RECEIPT MAILED
- 03 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Apr 2024 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 28 Mar 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB